文献速递呼吸衰竭与机械通气

无创通气治疗急性低氧性非高碳酸血症性呼吸衰竭:系统评价与Meta分析

Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在排除慢阻肺急性加重和心源性肺水肿的急性低氧性非高碳酸血症性呼吸衰竭成人中,无创通气较标准氧疗降低插管率和住院死亡率。

该系统评价与Meta分析检索PubMed、EMBASE、Cochrane图书馆、Web of Science及参考文献至2016年6月,纳入11项随机对照试验共1480例成人急性低氧性非高碳酸血症性呼吸衰竭患者,排除慢阻肺急性加重和心源性肺水肿。主要终点为插管率,次要终点为ICU死亡率和住院死亡率。与标准氧疗相比,无创通气显著降低插管率(汇总风险比0.59,95%CI 0.44-0.79,p=0.0004),并显著降低住院死亡率(风险比0.46,95%CI 0.24-0.87,p=0.02)。亚组分析显示双水平正压通气与ICU死亡率降低相关(p=0.007),头盔式无创通气可降低住院死亡率(p=0.0004),而面罩/鼻罩无创通气则不能。作者认为因试验数量有限,尚无足够科学证据推荐双水平正压通气或头盔式无创通气,需大型严谨随机试验回答这些问题。

要点

  • 纳入11项RCT共1480例成人急性低氧性非高碳酸血症性呼吸衰竭患者,排除慢阻肺急性加重和心源性肺水肿。
  • 与标准氧疗相比,无创通气显著降低插管率(汇总风险比0.59,95%CI 0.44-0.79,p=0.0004)。
  • 无创通气还显著降低住院死亡率(风险比0.46,95%CI 0.24-0.87,p=0.02)。
  • 亚组分析显示双水平正压通气与ICU死亡率降低相关(p=0.007)。
  • 头盔式无创通气可降低住院死亡率(p=0.0004),而面罩/鼻罩无创通气则不能。

适用人群与场景

  • 成人急性低氧性非高碳酸血症性呼吸衰竭患者,排除慢性阻塞性肺疾病急性加重和心源性肺水肿患者。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入11项随机对照试验共1480例患者,检索至2016年6月,采用随机效应模型分析。
  • 主要终点插管率:无创通气较标准氧疗显著降低,汇总风险比0.59(95%CI 0.44-0.79,p=0.0004)。
  • 次要终点住院死亡率:无创通气较标准氧疗显著降低,风险比0.46(95%CI 0.24-0.87,p=0.02)。
  • 亚组分析:应用双水平正压通气与ICU死亡率降低相关(p=0.007)。
  • 亚组分析:头盔式无创通气可降低住院死亡率(p=0.0004),而面罩/鼻罩无创通气则不能。

证据类型、等级与局限

  • 证据类型为系统评价与Meta分析,纳入随机对照试验,采用Cochrane偏倚风险工具评估内部真实性,采用GRADE方法评估证据强度。
  • 作者认为因试验数量有限,尚无足够科学证据推荐双水平正压通气或头盔式无创通气。
  • 作者指出需要大型严谨的随机试验来明确回答这些问题。

对床旁实践的改变

  • 在排除慢阻肺急性加重和心源性肺水肿的急性低氧性非高碳酸血症性呼吸衰竭成人中,无创通气较标准氧疗降低插管率和住院死亡率。
  • 作者认为因试验数量有限,尚无足够科学证据推荐双水平正压通气或头盔式无创通气。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the effectiveness of noninvasive ventilation in patients with acute hypoxemic nonhypercapnic respiratory failure unrelated to exacerbation of chronic obstructive pulmonary disease and cardiogenic pulmonary edema.

DATA SOURCES: PubMed, EMBASE, Cochrane library, Web of Science, and bibliographies of articles were retrieved inception until June 2016.

STUDY SELECTION: Randomized controlled trials comparing application of noninvasive ventilation with standard oxygen therapy in adults with acute hypoxemic nonhypercapnic respiratory failure were included. Chronic obstructive pulmonary disease exacerbation and cardiogenic pulmonary edema patients were excluded. The primary outcome was intubation rate; ICU mortality and hospital mortality were secondary outcomes.

DATA EXTRACTION: Demographic variables, noninvasive ventilation application, and outcomes were retrieved. Internal validity was assessed using the risk of bias tool. The strength of evidence was assessed using Grading of Recommendations Assessment, Development, and Evaluation methodology.

DATA SYNTHESIS: Eleven studies (1,480 patients) met the inclusion criteria and were analyzed by using a random effects model. Compared with standard oxygen therapy, the pooled effect showed that noninvasive ventilation significantly reduced intubation rate with a summary risk ratio of 0.59 (95% CI, 0.44-0.79; p = 0.0004). Furthermore, hospital mortality was also significantly reduced (risk ratio, 0.46; 95% CI, 0.24-0.87; p = 0.02). Subgroup meta-analysis showed that the application of bilevel positive support ventilation (bilevel positive airway pressure) was associated with a reduction in ICU mortality (p = 0.007). Helmet noninvasive ventilation could reduce hospital mortality (p = 0.0004), whereas face/nasal mask noninvasive ventilation could not.

CONCLUSIONS: Noninvasive ventilation decreased endotracheal intubation rates and hospital mortality in acute hypoxemia nonhypercapnic respiratory failure excluding chronic obstructive pulmonary disease exacerbation and cardiogenic pulmonary edema patients. There is no sufficient scientific evidence to recommend bilevel positive airway pressure or helmet due to the limited number of trials available. Large rigorous randomized trials are needed to answer these questions definitely.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Xu XP, Zhang XC, Hu SL, et al. Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis. Crit Care Med. 2017. PMID: 28441237. doi:10.1097/CCM.0000000000002361

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。